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Summary and conclusive remarks E
Summary
Introduction
Left ventricular dilation is the prerequisite of hearl failure, and is accompanied by
autonomic dysfunction and neurohormonal activation. Heaft failure research of the
University of Groningen (both at the Institute of Clinical Pharmacology and at the
University Hospital) has initially focused on measurement of plasma neurohormones.
More recently, other parameters of autonomic dysfunction have been evaluated. In this
thesis different autonomic mechanisms in the development of clinical and experimental
models of hearl failure have been investigated. and these are described in Part l. In
additron, since the beginning of the 1990's, the place of B-blockade has rapidly increased.
Potential mechanisms which may explain their benefit, and clinical use will be discussed
in Part 2.
Pa r t  1 :
ln chapter 2 a new model of herul failure in the rat rs described, which rs a combination
of systolic dysfunction (myocardial infarction), and diastolic dysfunction ( ..- systemic
hypertension), leading to augmented left ventricular dilation This cornbined model
consists of the rat myocardial infarction model, with an additronal increased afterload by
abdominal aorlic banding. Together with this combined model. the separate models are
studied. In myocardial infarction rats. baseline values of contractile function were
decreased, but not after inotropic stimulation. ln aortic banding rats. contractile
parameters were not significantly impaired, compared with controls. Both myocardial
infarction and the combined myocardial infarction/aortrc banding animals, but not aofiic
banding rats, had a significantly increased heart weight and increased left ventricular
cavity volume compared to conh'ol animals. lt is concluded that myocardial
infarction/aortrc banding provides a new experimental rnodel, which may yield important
information. Furlhennore, it provides insight into the pathophysiology allowing
evaluation of changes that may rnimic clinical myocardial infarction with additional
increased after load as obser.,red in chnical (concomitant) hypefiension.
R-adrenoceptor density or Bn,u, may also reflect autonomic tone, and is altered in
various cardiac diseases. It can be measured by invasive techniques using endomyocardial
biopsy material, and non-invasively using positron emission tomography (PET).
Chapter 3 gives a brief overuiew of several experimental models and pathophysiologic
circumstances, in which B-adrenoceptor density is changed. Furlhenrrore, in this chapter
the first results of clinical B-adrenoceptor measurements using PET in humans are
discussed. Using (S)-[1'C]-CGPl2l77 PET and standardized reorientation to ten short
Ll LAI' I l ,t( I U
axis slices, changes in B-receptor dish'ibution. e.g. due to rnyocardial infarction and
ischemia may be better identif ied and characterized. Additionally,. because its
non-invasive character. PEI' also provides the possibil i ty of serial measuremeuts. ancl
may elucidate the effects of different h'eatment stlategies in several heart diseases on
cardiac B-adrenergic receptors. In chapter 4 changes in f}-adrenoceptor density in
myocardial infarction urodel in rats are described. Twelve weeks after myocardial
infarction. a decleased R,-adrenoceptor density was found in tlre inlhrcted nryocardiunr,
compared with non-infarcted myocardiurn. This indicates that the surviving myocardial
cells irr the infarcted nryocaldium have a decreased 8",,, due to a decreased
B, -adrerroceplo l  derrs i t l  .
Decreased heart rate variabilrty (HRttl is another autonolnic parameter. and canies
prognostic value in heaftfailure. ln chapter 5. the acculacy and feasibil i ty of analvsis r 'rf
HRV usrng radio telernelr) 'to assess autonomic lunction in (1ree ly rnoving) healthy rats.
is described. Wrth radio telelnetl\ '- elech'ocardioglarns \\ 'ere otrtaincd duling autor.ronric
blockade and l,angcudorff perfirsion. Herealier. Fourier Transfbrrn r,r as pcrlbrmed on RR
inter.val t imes. The stuilv showed. that this techniclue is f-easitrle. aud rna-v thus bc used as
an experirneutal rnodel tt 'r inrestigate autorrotnic function.
Part 2z
While AC'E inhibitul t lr 'atl lrenl is ctulentlt ' the corrrerstorte of treatrnent rn hcart failurc.
recent  large-scale t l ia ls  ind icate that  l3-b lockers have s isn i f icant  addi t ive value in  th is
patient population. ln chrpter (r the nrechanistns involvecl in lefi ventricular cli lation atter
rnyocardia l  i r r farct icrn-  arrc l  the indiv idual  p lace of  AC'E inhib i tors and B-blockers.  and
oornbination" are discussed Inc,luded are the effects in the acute phase after rnyocardial
infarction and in the cirronic phasc of hcarl failure- and rnechanisrns regaldirrg rernodeling
are d iscusscd.  Basecl  on the bcnel ic ia l  e l l 'ects  o l 'A( 'E- inhib i t ion and B-blockade in acute
rnyocald ia l  i r r fh lc t ron aud in c l r ronrc hear l  fa i lurc.  in  t l r is  chapter  a t reatnrcr ' r t  shatcrr  rs
ptoposed in rvhich botlr A('E-inhibit ion and B-blockade are starled catly afier ttry trc:alclial
in larc l ion.
Despi te thc r isk associa lec l  r .v i th  in i t ia t ion and upt i t rat ion of  B-b lockade i r r  hear t
la i lure.  these drugs are inc leasingl l 'garn ing at tent ion as benef ic ia l  t leat lnent  in  hear l
f i r i lure.  Chapter  7 descr ibes the f 'easib i l i tv 'o f  out  of  hospi ta l  dose t i t ra t i t r r r  in  pet ient :
with idiopathic dilated carcliorny'opathy. To predict which patient wil l show a prolonged
titration tirnc and uil l  ntlt reaclr the targct dose or rreeds ad-juslrnent ol-corrcomitartt
t leatmcnt. patients werc ertensively studied. lnterestingly. failure of dose titration r,vas
only associated r.l i th low s1 stolic blood pressure. and lot r.vit lr palallretels of severitv ol-
heaft failure
t14
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ln the CIBIS I hial, btsoprolol was shown to be more beneficial in patients with heart
failure due to idropathic dilated cardiomyopathy than in those wrth hearl failure due to
ischernic dilated cardiomyopathy. Chapter 8 describes a 24-hour heaft rate sub-study of
the CIBIS I ft ial. In patients with idiopathic dilated cardiomyopathy, bisprolol caused a
significant declease in monring heart rate, but in patients with ischemic heafi failure
("ischemic dilated cardiomvopathy") there was no significant h'eatment efl 'ect. lt was
concluded that the obseryed differential effect on nronring hearl rate. possible as
ret' lection of reduced sympathetic activation, rnay' possibly lre the explanatlon for a
dilferent clinical effect. lt cannot be excluded however, that a higher dose ofbisoprolol
miqht also be beneficial in patients with ischemic dilated cardionryopathy.
While the beneficial effects of ACE-inhibitors on errdothelial function are
well-known. thc additive effects of add-on u-blockade on this parameter are unclear.
Given the favorable effects of add-on fl-blockade in recent lalge-scale trrals (and the
lcduction in ischernic events). the effects ofadd-on R blockade ou endothelial function
rvere investigated rn chapter 9. In this chapter. the etlect of ACE-inhibit ion and
cornbined AC[-inhibit ion + fJ-blsckade are investigated in rats with experirnental
rnrocardial infarction. whcre we looked at endothelial functron in relation to lefi
lerrtricular drlation. I}-r 'eccptol clensiN ancl neurohurnolal activation. Twelve u,ceks after'
rnvocardial irt lhrction. ir;thrct size was compalatrle in all infhrct groups. Endotheliuur
dependent rclaxation to acetylcholinc. hou'ever. was significantly decreased in the
uttl leated group and rvas sirnilarly preserved by captopril and cornbined captopli l
nretoplcllol. These results do not support the concc'pt. that thc observed benctlcial effects
of acld-on B-blockade in lteart failure are related to an ef'fbct on endothelial function
( 'onclus ive renr i t rks
l r rpa r t  l . t hc ra t rnode l  o l ' hea r1  f a r l u r c i ssuccess fu l l l ' used ton l casu reau ton t r r r r i cac t i v i t l  ,
as reflected b1' B-rcceptor densiry and heart rate variabtl it l '  In addition. these techniques
carr be uscd to assess dru-q-inducecl changcs. In conh'ast. at this nroment rneasur.ing lSmax
rr i th  Pt ' .1-  is  I to l  1 'e t  avar lablc  Whi lc  in i t ia l  s f r rd ies in  heal thv volunteers were feasib le.
l i r r thcr  esearch showcd t l ta t  th is  tccrhr t ic lue was not  ( r -et )  appl icable in  pat ients wi th hear t
I  t r i lurc.
ln  par l  2 .  the (add-on)  c f lec ls  ofU-blockade in hear l  Ia i lure arc i r rvest igated.  as rvel l  as
t t techanistns involved.  I ' l rc  resul ts  sugg,cst .  that  l rcar- t  ratc  ancl  i ts  va l iab i l i tv  are potent ia l
surrogate endpoints, since it con'elated with clinrcal erri lpoints l:ffects of enclothelial
function. howcver, are less clear. (Up)titratiorr of R-blockers in patients rvith heart fhilule
appears to be re lated to basel ine b lood prcssure.  and sulpr is ingl l ' .  r rot  to  othcr 'palarneters
o f severity of heart fai l ule
